| GC33738-100mg |
|
1477-68-5 |
3-Methoxytyramine hydrochloride (3-O-methyl Dopamine hydrochloride)
|
0 |
C9H14ClNO2 |
|
|
|
| GC33738-10mM(1mLinDMSO) |
|
1477-68-5 |
3-Methoxytyramine hydrochloride (3-O-methyl Dopamine hydrochloride)
|
0 |
C9H14ClNO2 |
|
|
|
| GC33737-100mg |
|
528-92-7 |
Apronal (Allylisopropylacetylurea)
|
0 |
C9H16N2O2 |
|
|
|
| GC33737-10mM(1mLinDMSO) |
|
528-92-7 |
Apronal (Allylisopropylacetylurea)
|
0 |
C9H16N2O2 |
|
|
|
| GC33736-25mg |
|
72122-62-4 |
β-Casomorphin, bovine (β-Casomorphin-7 (bovine))
|
0 |
C41H55N7O9 |
|
|
|
| GC33736-10mg |
|
72122-62-4 |
β-Casomorphin, bovine (β-Casomorphin-7 (bovine))
|
0 |
C41H55N7O9 |
|
|
|
| GC33736-5mg |
|
72122-62-4 |
β-Casomorphin, bovine (β-Casomorphin-7 (bovine))
|
0 |
C41H55N7O9 |
|
|
|
| GC33735-100mg |
|
622370-35-8 |
|
0 |
C28H16ClF6N5O |
|
|
|
| GC33735-50mg |
|
622370-35-8 |
|
0 |
C28H16ClF6N5O |
|
|
|
| GC33735-10mg |
|
622370-35-8 |
|
0 |
C28H16ClF6N5O |
|
|
|
| GC33735-5mg |
|
622370-35-8 |
|
0 |
C28H16ClF6N5O |
|
|
|
| GC33735-1mg |
|
622370-35-8 |
|
0 |
C28H16ClF6N5O |
|
|
|
| GC33735-10mM(1mLinDMSO) |
|
622370-35-8 |
|
0 |
C28H16ClF6N5O |
|
|
|
| GC33733-1mg |
|
235433-36-0 |
Prolactin Releasing Peptide (12-31), human
|
0 |
C104H158N32O26 |
|
|
|
| GC33733-500μg |
|
235433-36-0 |
Prolactin Releasing Peptide (12-31), human
|
0 |
C104H158N32O26 |
|
|
|
| GC33732-10mg |
|
108334-68-5 |
|
0 |
C68H122N20O18 |
|
|
|
| GC33732-5mg |
|
108334-68-5 |
|
0 |
C68H122N20O18 |
|
|
|
| GC33732-1mg |
|
108334-68-5 |
|
0 |
C68H122N20O18 |
|
|
|
| GC33731-5mg |
|
259525-01-4 |
|
0 |
C21H28FN3O |
|
|
|
| GC33731-1mg |
|
259525-01-4 |
|
0 |
C21H28FN3O |
|
|
|
